Alexandria Real Estate Equities, Inc. which can be found using ticker (ARE) have now 12 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $186.00 and $127.00 with the average target price sitting at $144.92. Given that the stocks previous close was at $121.84 and the analysts are correct then there would likely be a percentage uptick in value of 18.9%. The day 50 moving average is $122.69 and the 200 day moving average is $116.04. The market capitalization for the company is 20.85B. The stock price for the company is currently is currently $119.18 USD
The potential market cap would be $24,800,656,420 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 220.7, revenue per share of $16.89 and a 1.27% return on assets.
Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT). The Company owns, operates, develops and is focused on collaborative life science, agtech, and technology campuses in various cluster locations. It develops urban cluster campuses and ecosystems. Its properties are primarily located in various locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. It has approximately 432 properties in North America containing approximately 47.4 million rentable square feet (RSF) of operating properties and development and redevelopment of new Class A properties (under construction), including 64 properties that are held by consolidated real estate joint ventures and four properties that are held by unconsolidated real estate joint ventures. Its properties include 601, 611, and 651 Gateway Boulevard; Alexandria Center for Life Science-Durham; 275 Grove Street; SD Tech by Alexandria, and Other.
